These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 28115347

  • 1. Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism.
    Mishra NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, Faull K, Yoon A, Proctor R, Miro JM, Rybak MJ, Bayer AS, Arias CA, Sullam PM.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115347
    [Abstract] [Full Text] [Related]

  • 2. Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.
    Tran TT, Mishra NN, Seepersaud R, Diaz L, Rios R, Dinh AQ, Garcia-de-la-Maria C, Rybak MJ, Miro JM, Shelburne SA, Sullam PM, Bayer AS, Arias CA.
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509945
    [Abstract] [Full Text] [Related]

  • 3. Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria.
    Adams HM, Joyce LR, Guan Z, Akins RL, Palmer KL.
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223392
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
    Kebriaei R, Rice SA, Stamper KC, Seepersaud R, Garcia-de-la-Maria C, Mishra NN, Miro JM, Arias CA, Tran TT, Sullam PM, Bayer AS, Rybak MJ.
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962347
    [Abstract] [Full Text] [Related]

  • 5. Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
    Zapata B, Alvarez DN, Farah S, Garcia-de-la-Maria C, Miro JM, Sakoulas G, Bayer AS, Mishra NN.
    Curr Microbiol; 2018 Aug; 75(8):1062-1067. PubMed ID: 29651552
    [Abstract] [Full Text] [Related]

  • 6. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis-oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance.
    Mishra NN, Abdelhady W, Elsayed AM, Lapitan C, Proctor RA, Rybak MJ, Miro JM, Bayer AS.
    Antimicrob Agents Chemother; 2023 Apr 18; 67(4):e0147222. PubMed ID: 36877026
    [Abstract] [Full Text] [Related]

  • 7. Metabolic changes associated with adaptive resistance to daptomycin in Streptococcus mitis-oralis.
    Parrett A, Reed JM, Gardner SG, Mishra NN, Bayer AS, Powers R, Somerville GA.
    BMC Microbiol; 2020 Jun 15; 20(1):162. PubMed ID: 32539684
    [Abstract] [Full Text] [Related]

  • 8. Strain-Specific Adaptations of Streptococcus mitis-oralis to Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics.
    Mishra NN, Tran TT, Arias CA, Seepersaud R, Sullam PM, Bayer AS.
    Antibiotics (Basel); 2020 Aug 15; 9(8):. PubMed ID: 32824132
    [Abstract] [Full Text] [Related]

  • 9. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Garcia-de-la-Maria C, Xiong YQ, Pericas JM, Armero Y, Moreno A, Mishra NN, Rybak MJ, Tran TT, Arias CA, Sullam PM, Bayer AS, Miro JM.
    Antimicrob Agents Chemother; 2017 May 15; 61(5):. PubMed ID: 28264848
    [Abstract] [Full Text] [Related]

  • 10. Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides in Streptococcus mitis-oralis.
    Yeaman MR, Chan LC, Mishra NN, Bayer AS.
    Antibiotics (Basel); 2021 Apr 08; 10(4):. PubMed ID: 33918000
    [Abstract] [Full Text] [Related]

  • 11. Membrane Phenotypic, Metabolic and Genotypic Adaptations of Streptococcus oralis Strains Destined to Rapidly Develop Stable, High-Level Daptomycin Resistance during Daptomycin Exposures.
    Mishra NN, de Paula Baptista R, Tran TT, Lapitan CK, Garcia-de-la-Maria C, Miró JM, Proctor RA, Bayer AS.
    Antibiotics (Basel); 2023 Jun 21; 12(7):. PubMed ID: 37508179
    [Abstract] [Full Text] [Related]

  • 12. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.
    Tran TT, Panesso D, Mishra NN, Mileykovskaya E, Guan Z, Munita JM, Reyes J, Diaz L, Weinstock GM, Murray BE, Shamoo Y, Dowhan W, Bayer AS, Arias CA.
    mBio; 2013 Jul 23; 4(4):. PubMed ID: 23882013
    [Abstract] [Full Text] [Related]

  • 13. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
    García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2013 May 23; 57(5):2319-25. PubMed ID: 23478959
    [Abstract] [Full Text] [Related]

  • 14. Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model.
    Kebriaei R, Bayer AS, Lapitan CK, Rybak MJ, Somerville GA, Mishra NN.
    Antibiotics (Basel); 2022 Oct 13; 11(10):. PubMed ID: 36290066
    [Abstract] [Full Text] [Related]

  • 15. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM, Slavetinsky CJ, Kuhn S, Hauser JN, Nega M, Mishra NN, Gekeler C, Bayer AS, Peschel A.
    mBio; 2018 Dec 18; 9(6):. PubMed ID: 30563904
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of drug resistance: daptomycin resistance.
    Tran TT, Munita JM, Arias CA.
    Ann N Y Acad Sci; 2015 Sep 18; 1354():32-53. PubMed ID: 26495887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.